Sumeet Solanki

Sumeet Solanki

Auto-generated profile, based on publicly available information

Sumeet Solanki

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
How cell metabolism regulates DNA repair is incompletely understood. Here, we define a GTP-mediated signaling cascade that links metabolism to DNA repair and has significant therapeutic implications. GTP, but not other nucleotides, regulates the activity of Rac1, a guanine nucleotide-binding protein, which promotes the dephosphorylation of serine 323 on Abl-interactor 1 (Abi-1) by protein phosphatase 5 (PP5). Dephosphorylated Abi-1, a protein previously not known to activate DNA repair, promotes nonhomologous end joining. In patients and mouse models of glioblastoma, Rac1 and dephosphorylated Abi-1 mediate DNA repair and resistance to standard-of-care genotoxic treatments. The GTP–Rac1–PP5–Abi-1 signaling axis is not limited to brain cancer, as GTP supplementation promotes DNA repair and Abi-1-S323 dephosphorylation in nonmalignant cells and protects mouse tissues from genotoxic insult. This unexpected ability of GTP to regulate DNA repair independently of deoxynucleotide pools has important implications for normal physiology and cancer treatment. SIGNIFICANCE: A newly described GTP-dependent signaling axis is an unexpected link between nucleotide metabolism and DNA repair. Disrupting this pathway can overcome cancer resistance to genotoxic therapy while augmenting it can mitigate genotoxic injury of normal tissues. This article is featured in Selected Articles from This Issue, p. 5

19 May 2025 in Cancer Research
Verified
Journal Article
Closed access
SDStephen L. DeAngelo
Stephen L. DeAngelo
LZLiang Zhao
Liang Zhao
SDSofia Dziechciarz
Sofia Dziechciarz
MSMyungsun Shin
Myungsun Shin
SSSumeet Solanki
Sumeet Solanki
YSYatrik Shah
Yatrik Shah
Ferroptosis is a nonapoptotic form of cell death driven by iron-dependent lipid peroxide accumulation. Colorectal cancer cells feature elevated intracellular iron and reactive oxygen species that heighten ferroptosis sensitivity. The ferroptosis inducer (S)-RSL3 [(1S,3R)-RSL3] is widely described as a selective inhibitor of the selenocysteine-containing enzyme (selenoprotein) glutathione peroxidase 4 (GPX4), which detoxifies lipid peroxides using glutathione. However, through chemical controls using the (R) stereoisomer of RSL3 [(1R,3R)-RSL3] that does not bind GPX4, combined with inducible genetic knockdowns of GPX4 in colorectal cancer cell lines, we revealed in this study that GPX4 dependency does not always align with (S)-RSL3 sensitivity, thereby questioning the current characterization of GPX4 as the primary target of (S)-RSL3. Affinity pull-down mass spectrometry with modified (S)-RSL3 probes identified multiple selenoprotein targets, indicating broad selenoprotein inhibition. Further investigation of the therapeutic potential of broadly disrupting the selenoproteome as a therapeutic strategy in colorectal cancer showed that the selenoprotein inhibitor auranofin, an FDA-approved gold salt, chemically induced oxidative cell death and ferroptosis in colorectal cancer models in vitro and in vivo. Similarly, genetic perturbation of ALKBH8, a tRNA-selenocysteine methyltransferase required for selenoprotein translation, suppressed colorectal cancer growth. In summary, these findings recharacterize the mechanism of (S)-RSL3 beyond GPX4 inhibition and establish selenoproteome disruption as a colorectal cancer therapeutic strategy. Significance: Chemoproteomic profiling reveals that RSL3 functions through pan-selenoprotein inhibition beyond GPX4 and identifies ALKBH8, a tRNA-selenocysteine methyltransferase essential for selenoprotein translation, as a therapeutic target to disrupt redox balance in colorectal cancer. See related commentary by Short, p. 2775

10 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMegan L. Schaller
Megan L. Schaller
MSMadeline M. Sykes
Madeline M. Sykes
JMJoy Mecano
Joy Mecano
SSSumeet Solanki
Sumeet Solanki
WHWesley Huang
Wesley Huang
SLScott F Leiser
Scott F Leiser
Background and Aims: The intestine plays a key role in metabolism, nutrient and water absorption, and provides both physical and immunological defense against dietary and luminal antigens. The protective mucosal lining in the intestine is a critical component of intestinal barrier that when compromised, can lead to increased permeability, a defining characteristic of inflammatory bowel disease (IBD), among other intestinal diseases. Here, we define a new role for the flavin-containing monooxygenase (FMO) family of enzymes in maintaining a healthy intestinal epithelium. Methods: Using Caenorhabditis elegans we measure intestinal barrier function, actin expression, and intestinal damage response. In mice, we utilize an intestine-specific, tamoxifen- inducible knockout model of the mammalian homolog of Cefmo-2 , Fmo5, and assess histology, mucus barrier thickness, and goblet cell physiology. We also treat mice with the ER chaperone Tauroursodeoxycholic acid (TUDCA). Results: In nematodes, we find Cefmo-2 is necessary and sufficient for intestinal barrier function, intestinal actin expression, and is induced by intestinal damage. In mice, we find striking changes to the intestine within two weeks following Fmo5 disruption. Alterations include sex-dependent changes in colon epithelial histology, goblet cell localization, and mucus barrier formation. These changes are significantly more severe in female mice, mirroring differences observed in IBD patients. Furthermore, we find increased protein folding stress in Fmo5 knockout animals and successfully rescue the severe female phenotype with addition of a chemical ER chaperone. Conclusions: Together, our results identify a highly conserved and novel role for Fmo5 in the mammalian intestine and support a key role for Fmo5 in maintenance of ER/protein homeostasis and proper mucus barrier formation.

1 August 2025
Verified
Other
Open access
SDStephen L. DeAngelo
Stephen L. DeAngelo
LZLiang Zhao
Liang Zhao
SDSofia Dziechciarz
Sofia Dziechciarz
MSMyungsun Shin
Myungsun Shin
SSSumeet Solanki
Sumeet Solanki
YSYatrik Shah
Yatrik Shah
Supplementary Figure S7 shows the impact of AlkBH8 KD on GPX1/2 protein levels, CRC cell growth, colony formation, and tests the rescuing effects of sodium selenite under RSL3 and auranofin treatments.

12 January 2024
Verified
Other
Open access
PDF file
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Table S1 shows Supplementary Table S1 and relative references.

12 January 2024
Verified
Other
Open access
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Data 1 shows the original data of phosphoproteomic assay in Figure 2.